8
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61278 |
Aminopeptidase-IN-1
|
Aminopeptidase | Metabolism |
Aminopeptidase-IN-1 是一种有效的胰岛素调节氨肽酶 (IRAP) 抑制剂(Ki: 7.7 μM)。Aminopeptidase-IN-1 可用于认知和记忆障碍的研究。 | |||
T11221 |
ERAP1-IN-1
|
Others | Others |
ERAP1-in-1 是一种内质网氨基肽酶 1 (ERAP1) 抑制剂,能竞争性地抑制 ERAP1 对代表性生物底物九聚物肽的作用。 | |||
T60021 |
ecMetAP-IN-1
|
Others | Others |
ecMetAP-IN-1 可用作 QSAR 模型,以使用多元线性回归研究蛋氨酸氨基肽酶抑制剂作为抗癌剂。 | |||
T28482 |
Firibastat
QGC 001,QGC-001,RB-150,RB150,QGC001,RB 150 |
Aminopeptidase | Metabolism |
Firibastat (RB150) 是一种具有口服活性的 EC33 前体药物。Firibastat 是一种首创的脑氨基肽酶 A(APA) 抑制剂 (Ki=200 nM),选择性地抑制高血压大鼠脑血管紧张素 II 转化为血管紧张素 III,降低血压。 | |||
T61984 |
MtMetAP1-IN-1
|
||
MtMetAP1-IN-1 是一种蛋氨酸氨基肽酶1(MetAP1) 的抑制剂。MtMetAP1-IN-1 显示出抗分枝杆菌活性。 | |||
T61258 |
HFI-419
|
||
HFI-419 is a potent inhibitor of insulin-regulated aminopeptidase (IRAP) with a K i value of 0.48 μM. It is utilized in research pertaining to cognitive and memory impairments, including Alzheimer's disease, brain trauma, and stroke [1]. | |||
T61756 | APN/AKT-IN-1 | ||
APN/AKT-IN-1 is a potent dual inhibitor of aminopeptidase N (APN) and protein kinase B (AKT), exhibiting IC50 values of 0.21 μM and 0.27 μM for APN and AKT inhibition, respectively. This compound effectively suppresses the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), which serves as an intracellular substrate of AKT [1]. | |||
T76568 |
Aminopeptidase N Ligand (CD13) NGR peptide
|
||
AminopeptidaseN Ligand (CD13) NGR peptide 是靶向CD13的多肽,常见于癌症研究中,用作细胞内传递的载体介质。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1257 |
Bestatin
Ubenimex,乌苯美司 |
Others; Aminopeptidase; Antibacterial; Antibiotic; LTR | Immunology/Inflammation; Metabolism; Microbiology/Virology; Others |
Bestatin (Ubenimex) 是 CD13 (Aminopeptidase N)/APN 和 leukotriene A4 hydrolase 抑制剂,可用于癌症研究。 |